Indian Emuls (IEML)
Fast GrowerFairStock Score: 60/100 — STEADY
Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹358.5 |
| Market Cap | ₹503.19 Cr |
| P/E Ratio | 8.48 |
| ROCE | 23.57% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 47.13% |
| Debt/Equity | — |
| Sales Growth | 49.48% |
| Promoter Holding | 32.64% |
| 52-Week Range | ₹37.8 — ₹358.5 |
| Sector | Chemicals & Petrochemicals |
Strengths
- Sales growth of 49.48% and profit growth of 47.13% show strong business momentum.
- P/E of 8.48 and PEG of 0.18 suggest a significant margin of safety if growth is maintained.
- ROCE of 23.57% indicates efficient capital allocation and possible competitive strength.
- Piotroski F-Score of 7/9 reflects solid overall financial health.
- Latest quarter sales of ₹77 Cr and net profit of ₹10 Cr demonstrate continued operating traction.
Concerns
- Promoter holding of only 32.64% is low for an Indian small-cap, raising governance and alignment concerns.
- Zero dividend yield means shareholders receive no cash return if growth disappoints.
- 52-week range of ₹37.80 to ₹199.60 signals extreme volatility and possible cyclicality.
- Missing ROE, book value and debt/equity data makes a complete Graham-style margin-of-safety analysis impossible.
AI Analysis
I am not buying a ticker; I am buying a partnership. Indian Emuls, at ₹80.15 with a ₹141 crore market cap, sells at a P/E of 8.48. That is attractive only if the earnings power is real and durable. The recent record is certainly impressive: sales grew 49.48% and profits 47.13%, and the latest quarter delivered ₹77 crore in sales and ₹10 crore in profit. A 23.57% ROCE suggests management uses capital well—few businesses can earn that rate without some protection from competition. The Piotroski score of 7 out of 9 also points to fundamentals that pass Benjamin Graham's basic checks. At a PEG of 0.18, the market is not merely underestimating growth; it is almost refusing to believe it. I don't need to be a genius to see that if these numbers persist, this is extraordinarily cheap. But I must be careful. The 52-week range of ₹37.80 to ₹199.60 is a red flag disguised as volatility. A small specialty-chemical company can see earnings swing with raw-material costs, customer orders, and capacity. Promoter holding of only 32.64% is another concern; I want the captain to have a heavy stake in the ship. There is also no dividend, so my return will come solely from management's ability to reinvest. I cannot calculate ROE or book value because the data is not provided—something I would demand before committing real money. This could be a wonderful fast grower, but I would require a long record, low debt, and evidence that growth is not cyclical sugar. Price is what you pay; value is what you get. Here, I need to see more before I call it value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer